Next Article in Journal
In Response to: ‘Impact of Glycosylation on Effector Functions of Therapeutic IgG’ (Pharmaceuticals 2010, 3, 146–157)
Next Article in Special Issue
Cannabinoid-Induced Hyperemesis: A Conundrum—From Clinical Recognition to Basic Science Mechanisms
Previous Article in Journal
Use of p38 MAPK Inhibitors for the Treatment of Werner Syndrome

Cannabinoids and Viral Infections

Department of Biology, Center for Neural Science, NYU Cancer Institute and Department of Microbiology, New York University, 100 Washington Square East, New York, NY, 10003, USA
Pharmaceuticals 2010, 3(6), 1873-1886;
Received: 21 May 2010 / Revised: 28 May 2010 / Accepted: 9 June 2010 / Published: 9 June 2010
(This article belongs to the Special Issue Cannabinoids)
Exogenous cannabinoids or receptor antagonists may influence many cellular and systemic host responses. The anti-inflammatory activity of cannabinoids may compromise host inflammatory responses to acute viral infections, but may be beneficial in persistent infections. In neurons, where innate antiviral/pro-resolution responses include the activation of NOS-1, inhibition of Ca2+ activity by cannabinoids, increased viral replication and disease. This review examines the effect(s) of cannabinoids and their antagonists in viral infections. View Full-Text
Keywords: pathogens; virus infection; immunomodulation; inflammation pathogens; virus infection; immunomodulation; inflammation
Show Figures

Graphical abstract

MDPI and ACS Style

Reiss, C.S. Cannabinoids and Viral Infections. Pharmaceuticals 2010, 3, 1873-1886.

AMA Style

Reiss CS. Cannabinoids and Viral Infections. Pharmaceuticals. 2010; 3(6):1873-1886.

Chicago/Turabian Style

Reiss, Carol Shoshkes. 2010. "Cannabinoids and Viral Infections" Pharmaceuticals 3, no. 6: 1873-1886.

Find Other Styles

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Back to TopTop